Nerve growth factor in mouse and rat serum: correlation between bioassay and radioimmunoassay determinations.
High levels of nerve growth factor (NGF) determined by competition radioimmunoassay do not agree with values obtained by bioassay. This discrepancy is illustrated here with rat and mouse serum as examples in which values up to 1000 ng/ml have been found by using competition radioimmunoassays. An explanation for the discordant results is presented: serum components bind NGF with an intermediate affinity (Kd = 10(-7) M) but with a very large capacity (up to 0.5 mg of NGF per ml of rat serum). The binding of 125I-labeled NGF to serum components competes with the binding to the solid-phase antibodies (Kd = 10(-9)M) present in limiting amounts, according to the principle of competition radioimmunoassays. Thus, less radioactivity is recovered bound to the antibodies and this gives the erroneous impression that NGF is present. To overcome this difficulty, a two-site radioimmunoassay has been developed which utilizes nonlimiting numbers of antibody binding sites. This assay provides a reliable determination of NGF levels in serum and it can be shown that in rat and mouse serum (either sex) there is less than 5 ng of NGF per ml, in agreement with the results of the bioassay.
D000818:Animals; D000906:Antibodies; D001666:Binding Sites, Antibody; D001681:Biological Assay; D001798:Blood Proteins / Q000378:metabolism; D005727:Ganglia, Spinal; D051379:Mice; D009414:Nerve Growth Factors / Q000097:blood* / Q000276:immunology; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats
D000906:Antibodies; D001798:Blood Proteins; D009414:Nerve Growth Factors